Company intelligence / Profile preview
ModeX Therapeutics
Weston, Massachusetts, United States
- Ownership
- Private
- Employees
- ~200
- Development stage
- Phase 1
01
Overview
ModeX is developing multispecific antibodies and vaccines with the aim of improving efficacy, specificity, and safety over existing therapies. Lead programs target cancer and infectious diseases such as COVID‑19. The company’s lead oncology program uses tetraspecific antibodies to address tumor heterogeneity and resistance. Its infectious disease pipeline includes broadly neutralizing multispecific antibodies against SARS-CoV‑2 Omicron variants with superior potency compared to authorized monoclonal antibodies.[1][2] No late-stage or pivotal clinical results have been reported publicly as of May 2025.
- Therapeutic areas
- HematologyOncologyInfectious Diseases
- Modalities
- Multispecific antibodiesVaccinesFerritin nanoparticle-based biologics[1][2][4]
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Not specifically disclosed; company states it seeks collaborations with leading biopharma companies and academic institutions.[2]
Beyond the preview
Go deeper on ModeX Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ModeX Therapeutics.